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Abstract
Background: Genetic and environmental factors have important roles in multiple sclerosis (MS)
susceptibility. A clear parent of origin effect has been shown in several populations, perhaps
resulting from factors operating during gestation. Preterm birth (birth at less than 37 weeks
gestational age) has been shown to result in long-term health problems, including impaired
neurological development. Here, in a population-based cohort, we investigate whether preterm
birth increases the risk to subsequently develop MS.
Methods: We identified 6585 MS index cases and 2509 spousal controls with preterm birth
information from the Canadian Collaborative Project on Genetic Susceptibility to MS. Rates of
individuals born preterm were compared for index cases and controls.
Results:  There were no significant differences between cases and controls with respect to
preterm births. 370 (5.6%) MS index cases and 130 (5.2%) spousal controls were born preterm, p
= 0.41.
Conclusion: Preterm birth does not appear to contribute to MS aetiology. Other factors involved
in foetal and early development need to be explored to elucidate the mechanism of the increased
risk conferred by the apparent maternal effect.
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Background
Multiple sclerosis (MS) is a chronic inflammatory disease
of the central nervous system (CNS) characterized by
myelin loss, varying degrees of axonal pathology and pro-
gressive neurological dysfunction [1]. With a prevalence
of about 1/1000, MS is the most common cause of
acquired neurological disability in young adults of North-
ern European descent [1] other than trauma. The aetiol-
ogy of MS remains elusive. However, like most common,
complex traits, it is clear that genetic and environmental
components play important roles, both independently
and interactively [2].
A parent-of-origin effect (maternal) has been repeatedly
observed in MS, based on data from studies of half-sib-
lings [3], sibships including dizygotic twins [4], a large
extended Dutch pedigree [5] and avuncular pairs [6] as
well as a documented timing of birth effect [7]. The bio-
logical basis of this parent-of-origin effect is as yet
unknown, but may arise from environmental compo-
nents, gene-environment interactions and/or epigenetic
modifications.
A "preterm" birth is defined as occurring at less than 37
weeks gestational age [8]. Preterm birth has been increas-
ing in frequency over the last few decades in Western soci-
eties, now accounting for some 7% of all births in Canada
[9]. Although the cause of preterm labour has no precise
aetiology, several maternal risk factors have been impli-
cated, including smoking, stress, infection and nutritional
status [8]. Additionally, preterm birth has been observed
to vary seasonally [10]. With improvements in perinatal
care, such as surfactant therapy and ventilator strategies,
survival has steadily improved [8]. This however has been
accompanied by concerns about a higher risk of long term
health problems among survivors [11]. Although most
organs are immature, the brain and lungs are especially
susceptible to the consequences of preterm birth, leading
to high rates of neurological complications including cer-
ebral palsy, cognitive deficits and neuro-sensory impair-
ments [11]. Preterm birth has been shown to alter brain
structure with reduced total cerebral tissue volume and
delayed myelination compared to term births [12].
In MS, plaque load does not correlate with axonal loss
[13], the accumulation of axonal loss is associated with
irreversible disability [14] and natural history data show
that the progressive phase is an age-dependent degenera-
tive process [15]. Taken together, these data suggest that a
possible mechanism affecting neurodegeneration/neu-
rodevelopment may be involved in MS pathogenesis.
Here, in a population-based cohort, we investigate
whether preterm birth increases the risk to subsequently
develop MS. To the best of our knowledge, this is the first
study on this specific topic.
Methods
Cases and controls were identified through the popula-
tion-based, longitudinal Canadian Collaborative Project
on Genetic Susceptibility to Multiple Sclerosis
(CCPGSMS), the methodology of which has been previ-
ously described [16,17]. Briefly, specialist MS clinics in 11
cities across Canada use standardised, personally admin-
istered questionnaires to screen individuals with MS (MS
index cases) and to collect data about themselves and
their families. Each participating CCPGSMS site has
obtained ethical approval from the relevant institutional
review board. The entire project was reviewed and
approved by the University of British Columbia. The
CCPGSMS combines both genetic epidemiology and
molecular genetics to investigate the aetiology of MS. A
key strength of the CCPGSMS is that the MS study popu-
lation is derived from 14 regional clinics that have a
patient pool representative of the Canadian MS popula-
tion. This minimizes ascertainment biases inherent in
genetic epidemiological investigations and generates a
sufficiently large sample size from which significant
results from both molecular and epidemiological studies
can be attained. To date over 30,000 MS patients and their
families have been screened.
Specific to this study, preterm data was collected by tele-
phone interview with mothers of MS index cases and
spouse controls (the term "spouse" is used generically to
refer to legal spouse, same-sex partner or common law
partner). Each CCPGSMS index case and spouse control
(if available) was asked if he/she had a biological mother
who could provide information on the individual's early
life. If a positive answer was received the biological
mother of the case/control was contacted by a CCPGSMS
site research nurse and administered a standardised ques-
tionnaire, details of which are described in [16].
CCPGSMS site research nurses have all been trained by
personnel from the central CCPGSMS centre at the Uni-
versity of British Columbia. An individual was classed as
being born preterm if born at under 37 weeks gestational
age. It is well known that maternal recall of preterm birth
is sufficiently accurate for clinical and epidemiological use
[18], but the validity of this information was corroborated
by further information asked for on the standardised
questionnaire, including data about birth weight (less
than 5 pounds), length of hospital stay (average 5 to 7
days between 1940–1965, the peak time of birth of our
cases and controls), and the use of an incubator, as these
factors are known to be associated with preterm birth
[11,19]. If a mother could not remember exact details
and/or the supporting data did not fit criteria for a pre-BMC Neurology 2008, 8:30 http://www.biomedcentral.com/1471-2377/8/30
Page 3 of 5
(page number not for citation purposes)
term birth, the offspring was not classed as being born
preterm.
Statistical analyses
The Chi squared test was used to assess significance when
comparing index cases and controls for the rate of preterm
births. The Student's t-test was used to look for differences
in average gestational age. Logistic regression (using the R
statistical package) was used to assess the effect of preterm
birth, gender and the interaction thereof.
Results
Complete information from maternal informants on
weeks gestation at birth as well as birth weight, duration
of hospital stay, and the use of an incubator was available
for 6585 index cases and 2509 spousal controls. The clin-
ical and demographic details of the index cases and con-
trols are shown in Table 1.
Three hundred and seventy (5.6%) MS index cases and
130 (5.2%) spousal controls were born preterm. These
values were not significantly different; p = 0.41 (see Table
2). Given the marked yet expected difference between sex
ratios of index cases versus spousal controls because of the
female preponderance in MS [20], a sex-stratified compar-
ison was also carried out. No significant differences (p =
0.67 and p = 0.31 respectively) in the rates of preterm
birth were observed when comparing female cases (280;
5.6%) and controls (46; 6.0%) – or male cases (90; 5.6%)
and controls (84; 4.8%) (Table 2). This was confirmed by
logistic regression analysis, which showed an effect of sex
on the risk of MS (p < 1 × 10-16) but no effect of being born
preterm (p = 0.65), or an interaction effect between sex
and preterm birth (p = 0.31) on the likelihood of develop-
ing the disease.
The average gestational age of preterm MS index cases was
34.6 weeks compared to 34.2 weeks for controls (p = 0.25)
– see Table 2. No significant differences were also found
when stratifying by sex (average gestational age female
index cases born preterm = 34.7 weeks, average gesta-
tional age female controls born preterm = 34.8 weeks, p =
0.82; average gestational age male index cases born pre-
term = 34.2 weeks, average gestational age male controls
born preterm = 33.9 weeks, p = 0.52).
There were no differences in the number of individuals
born preterm between MS index cases and controls when
stratifying by month of birth or when stratifying MS index
cases by clinical course (data not shown).
Discussion
MS is a complex neurological trait with a parent-of-origin
(maternal) effect shown by several studies [3,5,6]. Intrau-
terine factors may potentially affect susceptibility to dis-
ease [4,7]. Preterm birth may have a seasonal basis [10]
and a timing of birth effect has been observed in MS [7].
Consequences of preterm birth may be detrimental neu-
rologically [11,12]. Taken together, it is possible that
being born prematurely may affect the risk to develop MS.
However, our data do not support this hypothesis.
Here, we observed no significant differences in preterm
births for cases or controls, even when stratifying by sex.
The mean gestational age for preterm cases and controls
was also similar (Table 2). Furthermore, stratification by
month of birth or clinical course found no significant dif-
ferences, however this analysis may have been underpow-
ered due to the sample size reduction upon stratification.
The clinical definition of preterm birth may not take into
account detrimental aspects of foetal development associ-
ated with premature birth measured in days rather than
weeks that may contribute to the onset of MS in adult-
hood. Development of gyri and sulci has been shown to
take place well into 40 weeks of gestational age [21], and
hence premature birth by even a few days may result in
small changes in brain structure. However, even when
analysing the data as above and including only individu-
als born up to and including 39 weeks gestational age,
there were no differences between MS cases and spousal
controls (data not shown). Greater understanding of foetal
development and early maternal influences on the foetus
and child is needed before the early origins of multiple
sclerosis can be assessed to a greater extent.
This study does not rule out maternal risk factors associ-
ated with preterm birth, for example smoking and infec-
tion, from MS disease pathogenesis, as these factors may
still have a role independent of any effect they may have
on premature birth.
Table 1: Clinical and demographic details of MS index cases and controls
MS Index Cases Spousal controls
n 6585 2509
Present mean age in years (SD) 49.0 (9.6) 50.9 (9.2)
Sex Ratio (f:m) 3.1:1 0.4:1
% Relapsing Remitting MS 67.9 /
SD = standard deviation, (f:m) = female to male sex ratioBMC Neurology 2008, 8:30 http://www.biomedcentral.com/1471-2377/8/30
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Our study may be limited in that maternal recall of data
may not be as accurate as data from clinical records etc.
Additionally, as we erred on the side of caution when clas-
sifying individuals as preterm, we may have missed those
who were born borderline preterm and hence we may be
underestimating the number of preterm births in our
cohort. However, this will apply equally to cases and con-
trols and maternal recall of preterm birth has been shown
to be accurate enough for epidemiological use [18].
Conclusion
It should be remembered that parent of origin effects can
arise in a number of ways, and likely also by other means
as yet undiscovered. These mechanisms include genomic
imprinting [22] and microchimerism [23]. We have previ-
ously shown that the rate of microchimerism is signifi-
cantly higher in affected MS twins than in unaffected co-
twins [24]. As a maternal influence in disease risk does not
appear to act via preterm birth, the mechanism of the
increased risk conferred maternally needs to be uncovered
by exploring all possible avenues.
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